Yuge Wang, Moxixuan Liu, Xuemei Jia, Qian Yang, Yao Du
{"title":"AMPK/mTOR/ULK1通路参与姜黄素诱导结直肠腺瘤小鼠模型自噬","authors":"Yuge Wang, Moxixuan Liu, Xuemei Jia, Qian Yang, Yao Du","doi":"10.1002/ddr.70115","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Colorectal adenoma (CRA) represents a pathological condition characterized by the aberrant development of intestinal epithelial cells and alterations in cellular differentiation within the colorectal mucosal epithelium, posing an increased risk for malignant transformation if not adequately addressed. Curcumin has been shown to exhibit a range of therapeutic effects across various diseases, which motivated this investigation utilizing C57BL/6 mice as a model system. Methodologies including hematoxylin-eosin staining (HE), western blot analysis, RT-PCR, immunofluorescence, and electron microscopy were employed to evaluate proteins associated with the <i>AMPK/mTOR/ULK1</i> signaling pathway. The study specifically examined variations in key autophagy-related proteins such as <i>Beclin-1, LC3, P62</i>, alongside intestinal junction proteins <i>Occludin, ZO-1, and Claudin-1</i>. This study seeks to elucidate whether curcumin can influence autophagy-related mechanisms in intestinal mucosal epithelial cells affected by colorectal adenoma to achieve potential therapeutic outcomes.</p>\n </div>","PeriodicalId":11291,"journal":{"name":"Drug Development Research","volume":"86 5","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AMPK/mTOR/ULK1 Pathway Participates in Autophagy Induction by Curcumin in Colorectal Adenoma Mouse Model\",\"authors\":\"Yuge Wang, Moxixuan Liu, Xuemei Jia, Qian Yang, Yao Du\",\"doi\":\"10.1002/ddr.70115\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <p>Colorectal adenoma (CRA) represents a pathological condition characterized by the aberrant development of intestinal epithelial cells and alterations in cellular differentiation within the colorectal mucosal epithelium, posing an increased risk for malignant transformation if not adequately addressed. Curcumin has been shown to exhibit a range of therapeutic effects across various diseases, which motivated this investigation utilizing C57BL/6 mice as a model system. Methodologies including hematoxylin-eosin staining (HE), western blot analysis, RT-PCR, immunofluorescence, and electron microscopy were employed to evaluate proteins associated with the <i>AMPK/mTOR/ULK1</i> signaling pathway. The study specifically examined variations in key autophagy-related proteins such as <i>Beclin-1, LC3, P62</i>, alongside intestinal junction proteins <i>Occludin, ZO-1, and Claudin-1</i>. This study seeks to elucidate whether curcumin can influence autophagy-related mechanisms in intestinal mucosal epithelial cells affected by colorectal adenoma to achieve potential therapeutic outcomes.</p>\\n </div>\",\"PeriodicalId\":11291,\"journal\":{\"name\":\"Drug Development Research\",\"volume\":\"86 5\",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-07-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Development Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/ddr.70115\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Development Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ddr.70115","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
AMPK/mTOR/ULK1 Pathway Participates in Autophagy Induction by Curcumin in Colorectal Adenoma Mouse Model
Colorectal adenoma (CRA) represents a pathological condition characterized by the aberrant development of intestinal epithelial cells and alterations in cellular differentiation within the colorectal mucosal epithelium, posing an increased risk for malignant transformation if not adequately addressed. Curcumin has been shown to exhibit a range of therapeutic effects across various diseases, which motivated this investigation utilizing C57BL/6 mice as a model system. Methodologies including hematoxylin-eosin staining (HE), western blot analysis, RT-PCR, immunofluorescence, and electron microscopy were employed to evaluate proteins associated with the AMPK/mTOR/ULK1 signaling pathway. The study specifically examined variations in key autophagy-related proteins such as Beclin-1, LC3, P62, alongside intestinal junction proteins Occludin, ZO-1, and Claudin-1. This study seeks to elucidate whether curcumin can influence autophagy-related mechanisms in intestinal mucosal epithelial cells affected by colorectal adenoma to achieve potential therapeutic outcomes.
期刊介绍:
Drug Development Research focuses on research topics related to the discovery and development of new therapeutic entities. The journal publishes original research articles on medicinal chemistry, pharmacology, biotechnology and biopharmaceuticals, toxicology, and drug delivery, formulation, and pharmacokinetics. The journal welcomes manuscripts on new compounds and technologies in all areas focused on human therapeutics, as well as global management, health care policy, and regulatory issues involving the drug discovery and development process. In addition to full-length articles, Drug Development Research publishes Brief Reports on important and timely new research findings, as well as in-depth review articles. The journal also features periodic special thematic issues devoted to specific compound classes, new technologies, and broad aspects of drug discovery and development.